Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride

Hepatology

Volumn 49, Issue 5, 2009, Pages 1683-1694

  Park, Ogyi ^a   Jeong, Won Il ^a   Wang, Lei ^a   Wang, Hua ^a   Lian, Zhe Xiong ^b   Gershwin, M Eric ^b   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CARBON TETRACHLORIDE; ALPHA-GALACTOSYLCERAMIDE; AUTACOID; GALACTOSYLCERAMIDE; GAMMA INTERFERON; STAT1 PROTEIN; STAT1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUSAL ATTRIBUTION; CELL KILLING; CHRONIC LIVER DISEASE; CONTROLLED STUDY; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; STELLATE CELL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMMUNOLOGY; ITO CELL; LIVER; LIVER CIRRHOSIS; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TOXIC HEPATITIS;

ANIMALS; CARBON TETRACHLORIDE; GALACTOSYLCERAMIDES; HEPATIC STELLATE CELLS; HEPATITIS, TOXIC; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; LIVER; LIVER CIRRHOSIS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; STAT1 TRANSCRIPTION FACTOR;

EID: 66149098871     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22813     Document Type: Article

References (45)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
2. Iredale JP. Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539-548.
3. Friedman SL, Rockey DC, Bissell DM. Hepatic fibrosis 2006: Report of the Third AASLD Single Topic Conference. HEPATOLOGY 2007;45: 242-249.
4. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
5. Friedman SL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172.
6. Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, et al. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 2004; 127:870-882.
7. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006;130:435-452.
8. Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, et al. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 2006;45:60-71.
9. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008;134: 657-667.
10. Muhanna N, Doron S, Wald O, Horani A, Eid A, Pappo O, et al. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis. HEPATOLOGY 2008;48:963-977.
11. Kronenberg M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu Rev Immunol 2005;23:877-900.
12. Seino K, Taniguchi M. Functionally distinct NKT cell subsets and subtypes. J Exp Med 2005;202:1623-1626.
13. Gao B, Jeong W, Tian Z. Liver: An organ with predominant innate immunity. HEPATOLOGY 2008;47;729-736.
14. Exley MA, Koziel MJ. To be or not to be NKT: Natural killer T cells in the liver. HEPATOLOGY 2004;40:1033-1040.
15. Emoto M, Kaufmann SH. Liver NKT cells: An account of heterogeneity. Trends Immunol 2003;24:364-369.
16. Ajuebor MN. Role of NKT cells in the digestive system. I. Invariant NKT cells and liver diseases: Is there strength in numbers? Am J Physiol Gastrointest Liver Physiol 2007;293:G651-G656.
17. Dennert G, Aswad F. The role of NKT cells in animal models of autoimmune hepatitis. Crit Rev Immunol 2006;26:453-473.
18. Halder RC, Aguilera C, Maricic I, Kumar V. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 2007;117:2302-2312.
19. Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 2005;175:1540-1550.
20. Ahmad A, Alvarez F. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J Leukoc Biol 2004;76:743-759.
21. Dong Z, Zhang J, Sun R, Wei H, Tian Z. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. HEPATOLOGY 2007;45:1400-1412.
22. Minagawa M, Deng Q, Liu ZX, Tsukamoto H, Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 2004;126:1387-1399.
23. Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y, Ridgway WM, et al. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. HEPATOLOGY 2008;47:571-580.
24. Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002; 123:1031-1043.
25. Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y, et al. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. HEPATOLOGY 2008;47:1317-1330.
26. Masson MJ, Carpenter LD, Graf ML, Pohl LR. Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide. HEPATOLOGY 2008;48:889-897.
27. Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004;127:1760-1774.
28. Notas G, Kisseleva T, Brenner D. NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009;130:16-26.
29. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-1626.
30. Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. HEPATOLOGY 2006;44:1441-1451.
31. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 2008;83:64-70.
32. Hobbs JA, Cho S, Roberts TJ, Sriram V, Zhang J, Xu M, et al. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J Virol 2001;75:10746-10754.
33. Harada M, Seino KI, Wakao H, Sakata S, Ishizuka Y, Ito T, et al. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int Immunol 2004;16:241-247.
34. Wintermeyer P, Cheng C, Gehring S, Hoffman B, Holub Brossay L, Gregory S. Invariant natural killer T cells suppresses the neutrophil inflammatory response in a mouse model of cholestatic liver damage. Gastroenterology 2008; doi: 10.1053/j.gastro.2008.10.027.
35. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007;26:117-129.
36. Rockey DC, Chung JJ. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. J Invest Med 1994;42:660-670.
37. Lang A, Sakhnini E, Fidder HH, Maor Y, Bar-Meir S, Chowers Y. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int 2005;25:808-816. HEPATOLOGY, Vol. 49, No. 5, 2009 PARK ET AL. 1693
38. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 1999;31:1120-1130.
39. Sun R, Park O, Horiguchi N, Kulkarni S, Jeong WI, Sun HY, et al. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. HEPATOLOGY 2006;44:955-966.
40. Yang L, Jhaveri R, Huang J, Qi Y, Diehl AM. Endoplasmic reticulum stress, hepatocyte CD1d andNKTcell abnormalities in murine fatty livers. Lab Invest 2007;87:927-937.
41. Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008;134:248-258.
42. Biburger M, Tiegs G. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. J Leukoc Biol 2008;84:264-279.
43. Parekh VV, Wilson MT, Olivares-Villagomez D, Singh AK, Wu L, Wang CR, et al. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 2005;115:2572-2583.
44. Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y. Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol 2007;19:1021-1029.
45. de Lalla C, Galli G, Aldrighetti L, Romeo R, Mariani M, Monno A, et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 2004;173:1417-1425.